SINTX Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
54.8%projected annual EPS growth
Analyst Coverage
4analysts covering
FY EPS (est.)
-$1.84next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly380K
Quarterly Net Loss Quarterly-2.8M
Stockholders' Equity Quarterly904K
Watch Items
- Nasdaq Listing Rule 5550(b)(1) Compliance Plan SubmissionTrigger: July 6, 2026 deadlineAction: Submit a comprehensive plan to regain compliance with the minimum $2.5 million stockholders' equity requirement.
- Commercialization of SINAPTIC Foot & Ankle Osteotomy Wedge SystemTrigger: Initial sales recorded in Q1 2026Action: Monitor surgeon adoption, clinical outcomes, and revenue contribution in subsequent quarters.
Research as of 20 Jun 2026